Get started
Author

Yi Hu

Observed names: Hu, Yi, Y. Hu, Yi Qi Hu, Yin Zhu
Observed institutions: Ningbo University, Central South University, Nanchang University, Sun Yat-sen University, Jinan University, Chinese University of Hong Kong, Capital Medical University, Washington University in St. Louis, First Affiliated Hospital of Jiangxi Medical College, Beijing Chest Hospital, Ningbo Medical Center Lihuili Hospital, Affiliated Hospital of Qingdao University, Central Hospital of Wuhan, Sun Yat-sen University Cancer Center, Ningbo University Affiliated Hospital, Third Xiangya Hospital, Tongji Hospital, Chinese People's Liberation Army, First Affiliated Hospital of Jinan University, First Affiliated Hospital of Nanchang University, State Key Laboratory of Oncology in South China, Huazhong University of Science and Technology
ORCID: 0000-0003-2708-7612
Observed ORCIDs: 0000-0003-2708-7612, 0000-0002-7561-2306
OpenAlex ID: A5041015485
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
2020 · Yan Xu, Zheng Xiang, et al. · Cellular and Molecular Immunology · 268
PDF
Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance
2017 · Yi Hu, Yin Zhu, et al. · Frontiers in Cellular and Infection Microbiology · 176
PDF
Systematic review with meta‐analysis: the global recurrence rate of Helicobacter pylori
2017 · Y. Hu, J.‐H. Wan, et al. · Alimentary Pharmacology & Therapeutics · 164
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
2019 · Mohammed Alnaggar, Yan Xu, et al. · Journal for ImmunoTherapy of Cancer · 133
PDF
Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway
2018 · Nianshuang Li, Yan Feng, et al. · Journal of Experimental & Clinical Cancer Research · 133
PDF
Primary Antibiotic Resistance of Helicobacter pylori in China
2017 · Yi Hu, Yin Zhu, et al. · Digestive Diseases and Sciences · 110
Recent progress in Helicobacter pylori treatment
2020 · Yi Hu, Yin Zhu, et al. · Chinese Medical Journal · 103
Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023
2023 · Li-Xiang Ling, Yaobin Ouyang, et al. · Journal of Nanobiotechnology · 69
PDF
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis
2023 · Ren‐Chun Du, Yang Zhang, et al. · Helicobacter · 68
PDF
Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection
2020 · Chuan Xie, Nianshuang Li, et al. · Gut Microbes · 68
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study
2022 · Yi Hu, Xin Xu, et al. · Helicobacter · 57
YAP and β-catenin cooperate to drive H. pylori -induced gastric tumorigenesis
2023 · Nianshuang Li, Xinbo Xu, et al. · Gut Microbes · 54
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis
2022 · Cong He, Chao Peng, et al. · Gastric Cancer · 53
PDF
Single-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori
2024 · Nianshuang Li, Sihai Chen, et al. · Journal of Advanced Research · 50
Alginate Oligosaccharide Ameliorates D‐Galactose‐Induced Kidney Aging in Mice through Activation of the Nrf2 Signaling Pathway
2021 · Hui Pan, Wenjing Feng, et al. · BioMed Research International · 50
PDF
Amoxicillin‐vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis
2022 · Yaobin Ouyang, Minghui Wang, et al. · Journal of Gastroenterology and Hepatology · 47
Can endoscopic ear surgery replace microscopic surgery in the treatment of acquired cholesteatoma? A contemporary review
2020 · Yi Hu, Bing Mei Teh, et al. · International Journal of Pediatric Otorhinolaryngology · 43
The Circadian Gene Per1 Plays an Important Role in Radiation-Induced Apoptosis and DNA Damage in Glioma
2019 · Ling Zhu, Qunli Wang, et al. · Asian Pacific Journal of Cancer Prevention · 43
PDF
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial
2024 · Yi Hu, Zhen-Yu Zhang, et al. · The Lancet Microbe · 42
Alginate oligosaccharide alleviates D‐galactose‐induced cardiac ageing via regulating myocardial mitochondria function and integrity in mice
2021 · Wenjing Feng, Jianya Liu, et al. · Journal of Cellular and Molecular Medicine · 42
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study
2023 · Yi Hu, Xin Xu, et al. · Frontiers in Immunology · 41
PDF
The Importance of Toll‐like Receptors in NF ‐κB Signaling Pathway Activation by Helicobacter pylori Infection and the Regulators of this Response
2016 · Yi Hu, Jian‐Ping Liu, et al. · Helicobacter · 41
Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway
2019 · Yi Hu, Jian-Ping Liu, et al. · Cancer Letters · 40
Analysis of key genes and signaling pathways involved in Helicobacter pylori‐associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data
2018 · Yi Hu, Cong He, et al. · Helicobacter · 40
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication
2022 · Yi Hu, Xin Xu, et al. · Frontiers in Cellular and Infection Microbiology · 37
Works count: 127
Citation count: 2,779
H-index: 30
I10-index: 58
Year
Topic
Type